Revolutionizing type 2 diabetes treatment: personalized approach shows promise in matching patients with optimal glucose-lowering therapies

FHS
August 10, 2023
10:37 am

A personalized therapy selection algorithm for two diabetes type 2 (T2D) treatment drug classes.

New fluorescent probe offers non-invasive detection of smell loss

A new fluorescent imaging probe can for the first time objectively and non-invasively measure loss of smell, clinically known as anosmia.

August 21, 2024

Opinion | Charting the Course: From Young Adult Leukemia Patient to Oncologist

Rosenthal is a lymphoma specialist. “Would you like to have a bone marrow biopsy today or tomorrow?” These are the only words I remember coming

December 4, 2023

Avian Flu Update: U.S. Announces More Than $175 Million to Track, Contain H5N1

The Biden administration is making more than $175 million in funds available on a variety of fronts to try to halt the spread of avian

May 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.